Do @entity1 whose @entity302 resolve, 'replace' them with other medically unexplained symptoms? Medically unexplained symptoms arising after a diagnosis of XXXX .

@entity1 @entity1109 @entity302 @entity130
BACKGROUND: In clinical practice, it is sometimes observed that @entity1 in whom @entity302 ( @entity302 ) cease, develop another @entity1109 ( @entity1109 ). METHODS: In order to determine how many @entity1 develop new @entity1109 post diagnosis and whether @entity1 whose attacks cease are more likely to do so, new @entity1109 were recorded 6-12 months after the diagnosis of @entity302 in 187 consecutive @entity1 . RESULTS: Compared with baseline, the overall proportion of @entity1 with @entity1109 increased slightly, from 70.1% to 76.5%, with 44/187 @entity1 (23.5%) developing new @entity1109 . There were no significant differences between attack free and non-attack free @entity1 . Binary logistic regression analysis showed that predictors of new @entity1109 diverged between attack free and non-attack free @entity1 . Among @entity1 continuing to have attacks, those with previous health related psychological @entity130 were 18.00 times more likely to develop new @entity1109 (p<0.0005). In @entity1 who became attack free, @entity1 drawing disability benefits were 5.04 times more likely to have new @entity1109 (p = 0.011). CONCLUSIONS: The results suggest that almost 25% of @entity1 develop new @entity1109 following a diagnosis of @entity302 , although most of those have @entity1109 pre-diagnosis. @entity1 with a history of health related psychological @entity130 whose attacks continue after diagnosis are at particularly high risk of developing new @entity1109 . The data do not support the hypothesis that @entity302 that resolve are likely to be 'replaced' by other @entity1109 .
